Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
RESTRICTED
Published on
Vincent Delatour, Noémie Clouet-Foraisona, Stéphane Jaisson, Patricia Kaiser and Philippe Gillery
Clinical Chemistry and Laboratory Medicine 2019;25(57)10:1623-1631
In this article Delatour and co-authors explore the trueness of external quality assessment (EQA) programmes for determining accuracy of HbA1c testing in diabetes (both lab-based and point-of-care systems). Commutability of processed EQA materials was found to be highly heterogeneou...
Investigating the quality of POCT devices for HbA1c: what are our next steps?
RESTRICTED
Published on
Erna Lenters-Westra and Emma English
Journal of Diabetes Science and Technology 2019;13(6):1154-1157
Lenters-Westra and English consider the pros and cons of different methods for evaluating the performance of HbA1c point-of-care testing (POCT) devices, including:
• CE marking for the European market
• Food and Drug Administration (FDA) clearance for the American market
• International Federation of Clinical Chemistry and Laboratory Medicine (...
Point-of-care testing for HbA1c: clinical need and analytical quality
RESTRICTED
Published on
Emma English, Larissa-Nele Schaffert and Erna Lenters-Westra
Clinical Laboratory International, November 2018
In this article, the authors discuss the benefits of point-of-care testing (POCT), from expediting diagnosis, to ease of monitoring, to cost and time efficiencies in rural and hard-to-reach environments. They go on to explain the different analytical methods for HbA1c measurement, the quality criteria for HbA1c POCT and the quality of P...
Access Now
By using this site, you agree with our use of cookies.
